ICU
Quality Rating
SeaStar Medical Holding Corporation (ICU), a biotechnology firm in the healthcare sector, develops extracorporeal therapies for treating hyperinflammation and cytokine storms in critically ill patients. The core business activities are permissible under Shariah principles, with no involvement in prohibited sectors. Financial screening indicates strong compliance in debt (0.21%) and liquidity (3.09%) ratios across standards, but the interest income ratio (2.27%) raises concerns due to historical exceedances in pre-revenue periods. The company is excluded from all major Shariah indices, leading to an overall non-compliant status. Investors should monitor revenue generation for potential future compliance improvements, with a purification requirement of 2.27%.
Purification Required
Moderate purification required - consider carefully
Index Inclusion
Excluded from S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, and Dow Jones Islamic Market (DJIM)
Key Compliance Considerations
- Historical interest income ratio exceedance due to zero revenue periods
- Pre-revenue stage causing financial volatility and index exclusions
Debt Ratio
0.0%
Liquidity Ratio
3.1%
Interest Income Ratio
2.3%
Purification
2.27%